Daniel Skiest is an Infectious Disease physician affiliated with Baystate Medical Center. OpenAlex indexes 1,143 publications with 7,747 citations (h-index 42); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3300 Main St
3rd Floor, Suite C&d
Springfield, MA 011071112
Telephone
413-794-7394Registry record last updated 18 Jan 2019.
Clinical trials
- HIV Testing in the Emergency Department at Baystate Medical Center: A Pilot Program
Sponsor: Baystate Medical Center
- Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
Sponsor: Community Research Initiative of New England
- BRAVO: Background Regimen of Raltegravir on Virologic Outcome
Sponsor: Community Research Initiative of New England
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20251 payment
- ViiV Healthcare CompanyProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
95.1%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor23.9%Tivicay61%Isentress20%Dovato19%Part D<11 patientsProtease Inhibitor22.7%Darunavir80%Ritonavir20%Part D<11 patients+ 6 more classes in this area
Genitourinary & hormones
4.9%Androgen4.9%Testosterone Cypionate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- HIV post-treatment controllers have distinct immunological and virological features
Proceedings of the National Academy of Sciences
2023 - Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
New England Journal of Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Prarthna Bhardwaj, MD
Baystate Medical Center
Quinn Pack, MD
Baystate Medical Center
Mara Slawsky, MD
Baystate Medical Center
Katie Nason, MD
Baystate Medical Center
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”